Hunan Hansen Pharmaceutical Co. Ltd. : Overvalued relative to peers, but may deserve another look
Categories: Yahoo Finance Hunan Hansen Pharmaceutical Co. Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 53. Our analysis is based on comparing Hunan Hansen Pharmaceutical Co. Ltd. with the following peers – Mayinglong Pharmaceutical Group Co., Ltd. Class A, Jiangsu Hengrui Medicine Co., Ltd. Class A, Jilin Zixin ... Read more (Read more...)